Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 84-87

  Guimarães, Elisalva T ^a   Lima, Milena S ^a   Santos, Luana A ^a   Ribeiro, Ivone M ^a   Tomassini, Therezinha B C ^a   Ribeiro Dos Santos, Ricardo ^a,b   Dos Santos, Washington L C ^a   Soares, Milena B P ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

Author keywords

Infections; Macrophages; Mice; Secosteroids; Therapy

Indexed keywords

AMPHOTERICIN B; ANTIPROTOZOAL AGENT; PHYSALIN B; PHYSALIN D; PHYSALIN F; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; MACROPHAGE; MOUSE; NONHUMAN; PHYSALIS; PHYSALIS ANGULATA; SKIN LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; PHYSALIS; SECOSTEROIDS; SKIN;

EID: 67249106620     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp170     Document Type: Article

References (10)

1. Lin YS, Chiang HC, Kan WS et al. Immunomodulatory activity of various fractions derived from Physalis angulata L. extract. Am J Chin Med 1992; 20: 233-43.
2. Chiang HC, Jaw SM, Chen CF et al. Antitumor agent, physalin F from Physalis angulata L. Anticancer Res 1992; 12: 837-43.
3. Nagafuji S, Okabe H, Akahane H et al. Trypanocidal constituents in plants. 4. Withanolides from the aerial parts of Physalis angulata. Biol Pharm Bull 2004; 27: 193-7.
4. Soares MBP, Bellintani MC, Ribeiro IM et al. Inhibition of macrophage activation and lipopolysaccharide-induced death by seco-steroids purified from Physalis angulata L. Eur J Pharmacol 2003; 459: 107-12.
5. Soares MBP, Brustolim D, Santos LA et al. Physalins B, F and G, seco-steroids purified from Physalis angulata L., inhibit lymphocyte function and allogeneic transplant rejection. Int Immunopharmacol 2006; 6: 408-14.
6. Teixeira MCA, Santos RJ, Sampaio RB et al. A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species. Parasitol Res 2002; 88: 963-8.
7. Guimarães ET, Santos LA, Ribeiro-dos-Santos R et al. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice. Microbes Infect 2006; 8: 1219-26.
8. Jacobo-Herrera NJ, Bremner P, Marquez N et al. Physalins from Witheringia solanacea as modulators of the NF-κB cascade. J Nat Prod 2006; 69: 328-31.
9. Seder RA, Gazzinelli R, Sher A et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-92.
10. Bogdan C, Moll H, Solbach W et al. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 1990; 20: 1131-5.